SAN DIEGO, July 8, 2015 /PRNewswire/ -- Human Longevity, Inc. (HLI), the genomics based, technology driven company, announced today that Kurt Oreshack has been hired as General Counsel. With degrees in law and philosophy with a focus on medical ethics, Oreshack brings years of experience as a corporate and securities attorney to help guide HLI's pioneering healthcare work.
Most recently, at Gunderson Dettmer LLP, Oreshack served as external General Counsel to over 100 private and public emerging growth companies in the biotechnology, pharmaceutical, medical device, cleantech and software industries. Human Longevity, Inc. has been working with Gunderson since the company's inception in March 2014, and Oreshack has been the point person for this work.
Oreshack is a Capital Markets expert, who has structured and negotiated hundreds of millions of dollars in debt and equity investments in private and public company clients. He has guided clients through all phases of IPO preparation and execution, and public company reporting and compliance. He has also led M&A teams in billions of dollars of transactions, representing both acquirors and acquisition targets.
"Kurt joins our team at an exciting time, as we are working to revolutionize the practice of medicine and enable pharmaceutical companies, insurers and healthcare providers to impact and improve health," said Dr. J. Craig Venter, Co-Founder and CEO of Human Longevity, Inc. "I'm thrilled to have Kurt's expertise, insight and leadership on our strong team of bio-informatics, science, medical and technology innovators."
Oreshack started his career at Luce, Forward, Hamilton & Scripps LLP (now Dentons), where he served as Securities counsel for over $3 billion in public offerings and private placements. Oreshack graduated cum Laude from Notre Dame Law School, where he was Production Editor of the Notre Dame Journal of Law, Ethics and Public Policy. He graduated Magna cum Laude from Loyola University Chicago.
SOURCE Human Longevity, Inc.